Navigation Links
Immune cells predict success of head and neck cancer treatment, U-M study finds
Date:4/26/2010

ANN ARBOR, Mich. Levels of a key type of immune cell are higher in head and neck cancer patients whose tumors are linked to the human papillomavirus, or HPV, according to researchers at the University of Michigan Comprehensive Cancer Center.

The finding suggests a way to predict which tumors are most likely to respond to chemotherapy and radiation and allow doctors to choose the best treatment option up front.

"In the past, we would give toxic chemotherapy to a patient, look at how the tumor responded and then decide whether the patient needed surgery or radiation. Now with patients who have HPV-positive cancers, this study suggests we can look in the microscope, measure the level of these immune cells and, based on that, select a treatment that is going to be potentially less toxic for the patient and most effective at curing the cancer," says study author Gregory T. Wolf, M.D., professor and chair emeritus of otolaryngology at the U-M Medical School.

Results of the study will be presented April 29 at the American Head and Neck Society annual meeting.

The researchers looked at 66 patients with oropharyngeal cancer, which includes cancers of the tonsils and the tongue base. They measured levels of several immune system cells in the blood and tracked HPV status.

The HPV-positive patients had higher levels of a subset of T-lymphocyte cells, a type of immune cell that is responsible for killing tumor cells. Patients who responded to an initial round of chemotherapy also had higher levels of these cells, while patients whose cancer recurred had lower levels.

"When we looked at how successful chemotherapy and radiation were, the levels of those killer T-lymphocyte cells predicted who was going to do well. That ability to predict response was even better than when we look at whether the tumors were HPV-positive or negative," says Wolf, director of the Head and Neck Cancer Specialized Program of Research Excellence at the U-M Comprehensive Cancer Center.

Previous studies have shown that HPV-positive head and neck cancers tend to be more responsive to current treatments, and these patients overall tend to have better outcomes than patients with HPV-negative tumors.

The researchers suggest that these new findings could help them devise strategies to boost the immune system of HPV-negative patients and improve the success rate of current therapies.

"We're actively pursuing how we can capitalize on this information and devise better immunotherapy approaches to head and neck cancer that would be less toxic than surgery or intensive radiation and hopefully cure more patients," Wolf says.

Head and neck cancer statistics: 35,720 Americans will be diagnosed with head and neck cancer this year and 7,600 will die from the disease, according to the American Cancer Society


'/>"/>

Contact: Nicole Fawcett
nfawcett@umich.edu
734-764-2220
University of Michigan Health System
Source:Eurekalert  

Related medicine news :

1. Skin Condition Vitiligo Tied to Immune System Dysfunction
2. Immune sensors suppress colitis-associated cancer
3. Tumors hide out from the immune system by mimicking lymph nodes
4. Tumors Use a Protein to Hide From Immune System
5. Optimism May Boost Immune System
6. Researchers discover fundamental step in immune-system development
7. Optimism boosts the immune system
8. Go with Your Gut and Boost your Immune System with America's Favorite Fruit
9. Study Details Machinery of Immune Protection Against Inflammatory Diseases Like Colitis
10. Targeting blood vessels, immune system may offer way to stop infection-caused inflammation
11. New approach to immune cell analysis seen as first step to better distinguish health and disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Immune cells predict success of head and neck cancer treatment, U-M study finds
(Date:12/5/2016)... , ... December 05, 2016 , ... Sabah Shah MD, MBA has joined the ... Group of New York was founded by James M. Maisel, MD and has been providing ... Shah has always followed a legacy of surpassing expectations amongst her peers. Growing up ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... won "Best Surgical Facial Rejuvenation" at the 2016 Anti-Aging & Beauty Awards ... , The Aesthetic & Anti-aging Medicine European Congress (AMEC) brings together ...
(Date:12/4/2016)... York, NY (PRWEB) , ... December 03, 2016 ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – hosted its first Swirl: A Wine Tasting Event in New York ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... Company in the Dallas area” Tuesday evening at the 26th Annual SMU Cox ... by SMU's Cox School’s Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges on regular ... to achieve optimal results. This important necessity inspired an inventor from Las Vegas, Nev., ... to ensure that people break or avoid bad techniques of brushing the teeth in ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 ... "In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, ... Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - ... market is valued at USD 60.22 Billion in ... a CAGR of 5.5% during the forecast period ...
(Date:12/2/2016)... , Dec. 2, 2016 In the ... sources apart from those derived from C. sativa, the ... Universita` di Napoli Federico II , the Universita` ... the first comprehensive, critical, integrated and unified inventory of ... article focuses on the remarkable chemical and structural ...
(Date:12/2/2016)... INDIANAPOLIS , Dec. 2, 2016  Eli Lilly ... its financial guidance for 2017 and provide updated financial ... will also conduct a conference call on that day ... the company,s financial guidance. The conference call ... the general public can access a live webcast of ...
Breaking Medicine Technology: